G. Lloyd
Keine laufenden Positionen mehr
Profil
G.
Kenneth Lloyd is the founder of GKOL, Inc. He worked as the Research Director at A.E.
Wyeth & Co., Vice Director at Sanofi SA, Director at Verne Mendel Medical Corp., Vice President-Biology & Drug Discovery at Sibia Neurosciences, Inc., Chief Scientific Officer & Senior VP-Research at Nereus Pharmaceuticals, Inc., and Assistant Vice President at Wyeth-Ayerst Research.
He also served as the Chief Scientific Officer at Dalian Wanchun Biotechnology Co. Ltd.
and is currently the Chief Scientific Officer at BeyondSpring, Inc. Dr. Lloyd obtained his undergraduate and graduate degrees from McGill University and his doctorate from the University of Toronto.
Ehemalige bekannte Positionen von G. Lloyd
| Unternehmen | Position | Ende |
|---|---|---|
| BEYONDSPRING INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.03.2024 |
| Dalian Wanchun Biotechnology Co. Ltd. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2014 |
Nereus Pharmaceuticals, Inc.
 Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | 29.04.2013 |
A.E. Wyeth & Co.
 A.E. Wyeth & Co. Miscellaneous Commercial ServicesCommercial Services Part of Vizards Staples & Bannisters, A.E. Wyeth & Co. is a legal services provider. The company is based in Dartford, UK. A.E. Wyeth was acquired by Vizards Staples & Bannisters on July 11, 2001. | Technik-/Wissenschafts-/F&E-Leiter | - |
| Sanofi SA | Corporate Officer/Principal | - |
Ausbildung von G. Lloyd
| McGill University | Graduate Degree |
| University of Toronto | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BEYONDSPRING INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
| Sibia Neurosciences, Inc. | Health Technology |
A.E. Wyeth & Co.
A.E. Wyeth & Co. Miscellaneous Commercial ServicesCommercial Services Part of Vizards Staples & Bannisters, A.E. Wyeth & Co. is a legal services provider. The company is based in Dartford, UK. A.E. Wyeth was acquired by Vizards Staples & Bannisters on July 11, 2001. | Commercial Services |
Nereus Pharmaceuticals, Inc.
Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA. | Commercial Services |
| Wyeth-Ayerst Research | |
| Sanofi SA | Health Technology |
| GKOL, Inc. | |
Verne Mendel Medical Corp.
 Verne Mendel Medical Corp. Pharmaceuticals: MajorHealth Technology Verne Mendel Medical Corp. develops pharmaceutical product candidates to treat mitochondrial degenerative diseases. Its products include candidates treat neurodegenerative group diseases, such as Parkinson’s, Alzheimer’s, and Lou Gehrig’s; stroke, glaucoma, deafness, and inherited mitochondrial diseases; and metabolic group diseases, including diabetes, and its cardiac and neurologic complications. The company is headquartered in San Diego, CA. | Health Technology |
| Dalian Wanchun Biotechnology Co. Ltd. |
